173 related articles for article (PubMed ID: 28762239)
21. Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Patel SH; Ismaiel OA; Mylott WR; Yuan M; Hauser KF; McRae M
Anal Chim Acta; 2019 May; 1056():79-87. PubMed ID: 30797464
[TBL] [Abstract][Full Text] [Related]
22. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.
Xue YJ; Pursley J; Arnold M
J Pharm Biomed Anal; 2007 Apr; 43(5):1728-36. PubMed ID: 17204392
[TBL] [Abstract][Full Text] [Related]
23. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
Fourati S; Charpentier C; Amiel C; Morand-Joubert L; Reigadas S; Trabaud MA; Delaugerre C; Nicot F; Rodallec A; Maillard A; Mirand A; Jeulin H; Montès B; Barin F; Bettinger D; Le Guillou-Guillemette H; Vallet S; Signori-Schmuck A; Descamps D; Calvez V; Flandre P; Marcelin AG;
J Antimicrob Chemother; 2015 May; 70(5):1507-12. PubMed ID: 25558077
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma.
Cozzi V; Charbe N; Baldelli S; Castoldi S; Atzori C; Cattaneo D; Clementi E
Ther Drug Monit; 2016 Jun; 38(3):407-13. PubMed ID: 26885814
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
Parsons TL; Marzinke MA
J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
[TBL] [Abstract][Full Text] [Related]
26. A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV Detection.
Wang X; Penchala SD; Amara A; Else L; McClure M; Boffito M
Ther Drug Monit; 2016 Jun; 38(3):327-31. PubMed ID: 26859200
[TBL] [Abstract][Full Text] [Related]
27. Determination of zolpidem in human plasma by liquid chromatography-tandem mass spectrometry for clinical application.
Byeon JY; Lee HI; Lee YJ; Lee JE; Kim SH; Kim YH; Na HS; Jang CG; Lee SY
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():129-34. PubMed ID: 25728370
[TBL] [Abstract][Full Text] [Related]
28. In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir.
Canducci F; Ceresola ER; Saita D; Castagna A; Gianotti N; Underwood M; Burioni R; Lazzarin A; Clementi M
J Antimicrob Chemother; 2013 Nov; 68(11):2525-32. PubMed ID: 23798668
[TBL] [Abstract][Full Text] [Related]
29. Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort.
Llibre JM; Montoliu A; Miró JM; Domingo P; Riera M; Tiraboschi J; Curran A; Homar F; Ambrosioni J; Abdulghani N; Force L; Peraire J; Casabona J;
HIV Med; 2019 Mar; 20(3):237-247. PubMed ID: 30688007
[TBL] [Abstract][Full Text] [Related]
30. The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
Dilly Penchala S; Alagaratnam J; Challenger E; Amara A; Else L; Winston A; Khoo S
Biomed Chromatogr; 2020 Jan; 34(1):e4711. PubMed ID: 31629375
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study.
Ni XJ; Wang ZZ; Shang DW; Zhang M; Hu JQ; Qiu C; Wen YG
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():247-52. PubMed ID: 24835512
[TBL] [Abstract][Full Text] [Related]
32. Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV.
Calcagno A; Moltó J; Borghetti A; Gervasoni C; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S
Clin Pharmacokinet; 2021 Jan; 60(1):103-109. PubMed ID: 32737820
[TBL] [Abstract][Full Text] [Related]
33. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
d'Arminio Monforte A; Cozzi-Lepri A; Di Biagio A; Marchetti G; Lo Caputo S; Rusconi S; Gianotti N; Mazzotta V; Mazzarello G; Costantini A; Castagna A; Antinori A;
J Antimicrob Chemother; 2019 May; 74(5):1363-1367. PubMed ID: 30698801
[TBL] [Abstract][Full Text] [Related]
34. Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots.
Akinloye A; Eniayewu O; Adeagbo B; Bolaji O; Olagunju A
Ther Drug Monit; 2022 Jun; 44(3):430-437. PubMed ID: 34629444
[TBL] [Abstract][Full Text] [Related]
35. A validated method for simultaneous quantification of four antiretrovirals in dried blood spot and plasma using LC-MS/MS: Application to efavirenz therapeutic drug monitoring in pregnant patients.
Ludna Duarte M; Mikaelle Brandão Silva A; Wellithom Viturino da Silva J; Pereira Santana D; Victor de Castro W; Cláudio Arraes de Alencar L; César Galindo Bedor D; Bastos Leal L
Clin Biochem; 2024 May; 127-128():110765. PubMed ID: 38649089
[TBL] [Abstract][Full Text] [Related]
36. SPE-UPLC-MS/MS method for sensitive and rapid determination of aripiprazole in human plasma to support a bioequivalence study.
Patel DP; Sharma P; Sanyal M; Shrivastav PS
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():20-5. PubMed ID: 23510852
[TBL] [Abstract][Full Text] [Related]
37. Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies.
Wojnicz A; Belmonte C; Koller D; Ruiz-Nuño A; Román M; Ochoa D; Abad-Santos F
J Pharm Biomed Anal; 2018 Mar; 151():116-125. PubMed ID: 29324280
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a LC-MS/MS method with electrospray ionization for determination of LASSBio-579 in rat plasma.
Conrado DJ; Palma EC; Fraga CA; Barreiro EJ; Rates SM; Dalla Costa T
J Pharm Biomed Anal; 2007 Jan; 43(2):677-82. PubMed ID: 16979864
[TBL] [Abstract][Full Text] [Related]
39. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G
J Pharm Biomed Anal; 2011 Mar; 54(4):779-88. PubMed ID: 21071165
[TBL] [Abstract][Full Text] [Related]
40. Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study.
Dalpiaz A; Marchetti N; Cavazzini A; Pasti L; Velaga S; Gavini E; Beggiato S; Ferraro L
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():72-8. PubMed ID: 22743338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
